Form 4: Neogen CEO John Edward Adent Acquires 23,035 Shares of Common Stock
SEC Form 4
Neogen CEO John Edward Adent purchased 23,035 shares of common stock at a price of $11.03 per share on January 16, 2025.
Summary
- John Edward Adent, CEO of Neogen Corp, acquired 23,035 shares of common stock on January 16, 2025.
- The purchase price was $11.03 per share.
- Following the transaction, Mr. Adent directly owns 269,164 shares of Neogen common stock.
Sentiment
Score: 7
Explanation: The document reflects a positive sentiment due to the CEO's purchase of shares, which can be interpreted as a sign of confidence in the company. However, it is a routine transaction and not a major event.
Positives
- The CEO's purchase of shares may indicate confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, which is common when company insiders trade shares. It provides transparency into the transactions of company executives.
Comparison to Industry Standards
- SEC Form 4 filings are a standard practice for publicly traded companies, and this transaction is consistent with typical insider trading activity.
- The purchase of shares by the CEO is a common occurrence and is not unusual in the context of corporate governance.
Stakeholder Impact
- The CEO's purchase of shares may positively influence investor confidence.
Key Dates
| Date | Description |
|---|---|
| 01/16/2025 | Date of the stock purchase transaction by CEO John Edward Adent. |
Keywords
Neogen, CEO, John Edward Adent, stock purchase, insider trading, common stock, share acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.